StockNews.AISignal intelligence
Company intelligence

SPRO

Spero Therapeutics, Inc. · NASDAQ · Healthcare

Price$1.03+0.98% · +$0.01
Market cap59.98MEquity value
P / E4.3Trailing ratio
Volume186.67KLatest session
Market data

SPRO price chart

TradingView
Related signals
1 min delayed

Browse public SPRO signals with their source context and measured market impact. Open any signal for its permanent analysis page.

SPROOct 28, 2026-1.32% since signal

Cantor Fitzgerald Initiates SPRO with Overweight and $6 Target

Cantor Fitzgerald started SPRO with an Overweight rating and a $6 price target, spotlighting meaningful upside for a stock trading near $1.14. While the piece also notes numerous other analysts initiating coverage on different biotechs, SPRO is the focal point for potential re-rating. If the target proves credible and coverage expands, SPRO could attract momentum buyers and improve near-term liquidity.

View signal analysis
Research

Company intelligence